Diabetes and pancreatic cancer.

There is great emphasis on early identification of high risk patients for developing pancreatic cancer in an attempt to reduce the burden of the fourth leading cause of cancer death in the United States. Abstracts presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted and supported the relationship between pancreatic cancer and diabetes mellitus and Abstract #4039 showed that hemoglobin-A1c at the time of diagnosis correlates with disease stage and predicts survival among all stages of pancreatic cancer patients. Abstracts #4044 and #e15110 also presented in 2013 ASCO Annual Meeting showed that metformin treatment serves as a positive prognosticator, especially in patients with diabetes mellitus diagnosed within 2 years of pancreatic cancer and in stage 3 pancreatic cancer patients with diabetes mellitus.

[1]  Hao Li,et al.  Association of metformin use with cancer incidence and mortality: a meta-analysis. , 2013, Cancer epidemiology.

[2]  Y. Bang,et al.  The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy. , 2013 .

[3]  T. Pawlik,et al.  Hemoglobin-A1c level to predict for clinical outcomes in patients with pancreatic cancer. , 2013 .

[4]  K. Helvacı,et al.  Metformin in diabetic pancreatic cancer patients: Benefit or not—Multicenter experience. , 2013 .

[5]  R. Andersson,et al.  Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells , 2013, BMC Cancer.

[6]  N. Sasahira,et al.  Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[7]  Tzeng-Ji Chen,et al.  Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan. , 2013, Internal medicine.

[8]  M. Murad,et al.  Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.

[9]  K. Ohtomo,et al.  Incidental Pancreatic Cysts Found by Magnetic Resonance Imaging and Their Relationship With Pancreatic Cancer , 2012, Pancreas.

[10]  Jun Liu,et al.  Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. , 2011, European journal of cancer.

[11]  Manal M. Hassan,et al.  Effect of metformin on survival of diabetic patients with pancreatic adenocarcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  I. Makhoul,et al.  Pancreatic cancer and diabetes mellitus: A retrospective cohort study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Meei-Shyuan Lee,et al.  Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals , 2011, BMC Cancer.

[14]  G. Krejs.  Pancreatic Cancer: Epidemiology and Risk Factors , 2010, Digestive Diseases.

[15]  Mariza de Andrade,et al.  Temporal Association of Changes in Fasting Blood Glucose and Body Mass Index With Diagnosis of Pancreatic Cancer , 2009, The American Journal of Gastroenterology.

[16]  G. Eibl,et al.  Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. , 2009, Cancer research.

[17]  Ananda Basu,et al.  Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. , 2008, Gastroenterology.

[18]  Franco Berrino,et al.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. , 2007, The Lancet. Oncology.

[19]  V. Beral,et al.  Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis , 2007, British Journal of Cancer.

[20]  M. Woodward,et al.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.

[21]  P. Pour,et al.  Diabetes mellitus: a risk factor for pancreatic cancer? , 2005, Langenbeck's Archives of Surgery.

[22]  J. Samet,et al.  Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.

[23]  X. Ding,et al.  Prevention of pancreatic cancer induction in hamsters by metformin. , 2001, Gastroenterology.

[24]  M. Tempero,et al.  AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. , 1999, Gastroenterology.

[25]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[26]  R. DeFronzo,et al.  Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[28]  L. Gullo,et al.  Diabetes and the risk of pancreatic cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  L. Jorfeldt,et al.  Pancreatic cancer is associated with impaired glucose metabolism. , 1993, The European journal of surgery = Acta chirurgica.

[30]  E. Lapi,et al.  [Effects of dimethylbiguanide (metformin) on peripheral insulin clearance and lipid biosynthesis in obese dyslipidemic subjects with and without diabetes mellitus]. , 1979, Clinica Terapeutica.

[31]  A. Basu,et al.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. , 2009, The Lancet. Oncology.

[32]  M. de Andrade,et al.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. , 2008, Gastroenterology.

[33]  E. Dimagno.  Pancreatic cancer: clinical presentation, pitfalls and early clues. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  L. Gullo,et al.  Diabetes and the risk of pancreatic cancer. , 1994, The New England journal of medicine.